Pharma IP Rights In China: Avoiding The Antitrust Pitfalls
Antitrust authorities globally are grappling with competition claims in the pharmaceutical sector. Recognizing that inventive pharmaceutical companies are entitled to protect their valuable intellectual property rights, antitrust authorities or courts will...To view the full article, register now.
Already a subscriber? Click here to view full article